Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Cancellieri

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Cancers|June 26, 2026
From Clinical Trials to Real-World Practice: Surgical Feasibility and Postoperative Outcomes After Neoadjuvant Chemoimmunotherapy for Locally Advanced NSCLC in a Single-Center ExperienceFilippo Lococo, Dania Nachira, Khrystyna Kuzmych, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2010
Neurotensin receptor 1 determines the outcome of non-small cell lung cancerMarco Alifano, Frédérique Souazé, Sandra Dupouy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trialFederico Cappuzzo, Claudia Ligorio, Pasi A Jänne, et al.
Journal of the National Cancer Institute|August 5, 2004
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFederico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.
Genes|June 26, 2026
LANTERN 2: Association Between Gene Molecular Profile and STAS in Lung Adenocarcinoma: A Comparative Analysis in a Prospective Real-World PopulationCarolina Sassorossi, Davide Dalfovo, Elisa De Paolis, et al.
International Journal of Molecular Sciences|September 14, 2024
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target TherapiesFilippo Lococo, Elisa De Paolis, Jessica Evangelista, et al.
Clinical Lung Cancer|April 15, 2023
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative ResultsFilippo Lococo, Alessandra Cancellieri, Marco Chiappetta, et al.
Haematologica|June 7, 2007
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphomaPier Luigi Zinzani, Monica Tani, Rocco Trisolini, et al.
ERJ Open Research|December 10, 2025
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia associated with lung adenocarcinoma: clinical, pathological and oncological outcomes from a multicentre analysisMaria Teresa Congedo, Dania Nachira, Alessandra Cancellieri, et al.
Histopathology|May 31, 2017
Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosisAnna Caliò, Veronica Lever, Andrea Rossi, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Cancers|June 26, 2026
From Clinical Trials to Real-World Practice: Surgical Feasibility and Postoperative Outcomes After Neoadjuvant Chemoimmunotherapy for Locally Advanced NSCLC in a Single-Center ExperienceFilippo Lococo, Dania Nachira, Khrystyna Kuzmych, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2010
Neurotensin receptor 1 determines the outcome of non-small cell lung cancerMarco Alifano, Frédérique Souazé, Sandra Dupouy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trialFederico Cappuzzo, Claudia Ligorio, Pasi A Jänne, et al.
Journal of the National Cancer Institute|August 5, 2004
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFederico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.
Genes|June 26, 2026
LANTERN 2: Association Between Gene Molecular Profile and STAS in Lung Adenocarcinoma: A Comparative Analysis in a Prospective Real-World PopulationCarolina Sassorossi, Davide Dalfovo, Elisa De Paolis, et al.
International Journal of Molecular Sciences|September 14, 2024
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target TherapiesFilippo Lococo, Elisa De Paolis, Jessica Evangelista, et al.
Clinical Lung Cancer|April 15, 2023
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative ResultsFilippo Lococo, Alessandra Cancellieri, Marco Chiappetta, et al.
Haematologica|June 7, 2007
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphomaPier Luigi Zinzani, Monica Tani, Rocco Trisolini, et al.
ERJ Open Research|December 10, 2025
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia associated with lung adenocarcinoma: clinical, pathological and oncological outcomes from a multicentre analysisMaria Teresa Congedo, Dania Nachira, Alessandra Cancellieri, et al.
Histopathology|May 31, 2017
Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosisAnna Caliò, Veronica Lever, Andrea Rossi, et al.
Pageof 10